DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,272 | – | 100 | +9900.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $119,000 | -48.0% | 12,830 | -45.2% | 0.00% | – |
| Q4 2021 | $229,000 | +151.6% | 23,424 | +770.1% | 0.00% | – |
| Q3 2021 | $91,000 | -14.2% | 2,692 | -7.4% | 0.00% | – |
| Q2 2021 | $106,000 | -27.9% | 2,907 | +12.5% | 0.00% | – |
| Q4 2020 | $147,000 | +37.4% | 2,584 | -0.9% | 0.00% | -100.0% |
| Q1 2020 | $107,000 | -85.6% | 2,607 | -78.2% | 0.00% | -80.0% |
| Q4 2019 | $743,000 | +143.6% | 11,937 | +32.8% | 0.01% | +150.0% |
| Q3 2019 | $305,000 | +771.4% | 8,990 | +898.9% | 0.00% | – |
| Q3 2018 | $35,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |